Rievent · Enduring Material
Optimizing Outcomes in Relapsed/Refractory NHL: Bringing CAR T-Cell Therapies to Rural and Underserved Communities
This activity reviews CAR T-cell therapy for relapsed/refractory non-Hodgkin lymphoma and strategies to improve timely referral, adverse event management, and post-infusion care.